Cannabinoid-Based Therapy Patent For Cachexia

WashingtonIt is estimated that a population of approximately 1.3 million are experiencing cachexia associated with cancer, multiple sclerosis, Parkinson’s disease, HIV/AIDS and other progressive illnesses. Cancer induced anorexia cachexia is responsible for about 20% of all cancer deaths. “We believe our therapy, subject to controlled testing, could offer an alternative to a common and difficult condition that accompanies those suffering from severe illness.

This patent filing for cachexia is an additional component of our core strategy that is intended to build a product portfolio of cannabinoid-based therapies for the treatment of a wide range of therapeutic indications including pain, epilepsy, and other niche severe terminal diagnosis, which are either life altering or life threatening.

To read more, visit http://finance.yahoo.com/news/patent-cannabinoid-based-therapy-cachexia-120000816.html

Posted in: News

Comments are closed.